title: Pathologic complete responses after chemotherapy plus figitumumab in stage IV non-small-cell lung cancer.
authors.affiliation: Hospital Universitario Virgen del Rocío, Seville, Spain.
authors.forename: Jesús
authors.initials: J
authors.lastname: Corral
authors.forename: José L
authors.initials: JL
authors.lastname: López-Villalobos
authors.forename: Lourdes
authors.initials: L
authors.lastname: Gomez-Izquierdo
authors.forename: Isabel
authors.initials: I
authors.lastname: Borrego
authors.forename: Luis
authors.initials: L
authors.lastname: Paz-Ares
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001707:Biopsy, Needle; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology* / Q000601:surgery; D008875:Middle Aged; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000379:methods; D049268:Positron-Emission Tomography; D012074:Remission Induction / Q000379:methods; D012907:Smoking / Q000009:adverse effects; D014057:Tomography, X-Ray Computed
chemical_list: D000911:Antibodies, Monoclonal; D016756:Immunoglobulins, Intravenous; C525021:figitumumab